Viewing StudyNCT00239239



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00239239
Status: COMPLETED
Last Update Posted: 2010-03-05
First Post: 2005-10-13

Brief Title: Fractionated Dosing Study Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Cancer
Non-Myeloid Malignancies
Anemia
Keywords:
Name View
Amgen View
Non-myeloid malignancy View
Chemotherapy-induced anemia View
Oncology View
Clinical Trials View
Pharmacokinetics View
Darbepoetin alfa View
Aranesp View